Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Alloway

Showing results (11-20 of 164) with videos related to

Pageof 17
Sort By:
Current Opinion in Organ Transplantation|July 15, 2011
Proteasome inhibitor treatment of antibody-mediated allograft rejectionE Steve Woodle, Rita R Alloway, Alin Girnita
Clinical Transplants|August 7, 2014
Plasma cell biology: principles for therapeutic designE Steve Woodle, Rita R Alloway, Nicole Schmidt Ejaz
The British Journal of Psychiatry : the Journal of Mental Science|July 1, 1988
Physical complications in anorexia nervosa. Haematological and neuromuscular changes in 12 patientsR Alloway, E Shur, R Obrecht, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1985
Neuropathy and myopathy in two patients with anorexia and bulimia nervosaR Alloway, E H Reynolds, E Spargo, et al.
Clinical Transplantation|May 2, 2002
A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysisRobert J Stratta, Rita R Alloway, Ernest Hodge, et al.
Transplantation Proceedings|November 22, 2005
Impact of the metabolic syndrome on long-term outcomes in simultaneous kidney-pancreas transplantationJ Rogers, R J Stratta, A Lo, et al.
Transplantation Proceedings|November 22, 2005
Inferior late functional and metabolic outcomes in African American simultaneous kidney-pancreas recipientsJ Rogers, R J Stratta, A Lo, et al.
Transplantation|April 30, 2003
Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized studyRobert J Stratta, Rita R Alloway, Agnes Lo, et al.
Journal of the Royal Society of Health|August 1, 1997
Lessons to be learned: a case study approach. Hyperactivity and confusion in the presentation of hyoscine overdoseN Ayub, D Donaldson, D Bedford, et al.
Transplantation Proceedings|November 22, 2005
Risk factors and outcomes analyses at 36 months of a prospective, randomized, multicenter, trial of daclizumab induction in simultaneous kidney-pancreas transplant recipientsR J Stratta, R R Alloway, A Lo, et al.
Pageof 17

Showing results (11-20 of 164) with videos related to

Sort By:
Pageof 17
Current Opinion in Organ Transplantation|July 15, 2011
Proteasome inhibitor treatment of antibody-mediated allograft rejectionE Steve Woodle, Rita R Alloway, Alin Girnita
Clinical Transplants|August 7, 2014
Plasma cell biology: principles for therapeutic designE Steve Woodle, Rita R Alloway, Nicole Schmidt Ejaz
The British Journal of Psychiatry : the Journal of Mental Science|July 1, 1988
Physical complications in anorexia nervosa. Haematological and neuromuscular changes in 12 patientsR Alloway, E Shur, R Obrecht, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1985
Neuropathy and myopathy in two patients with anorexia and bulimia nervosaR Alloway, E H Reynolds, E Spargo, et al.
Clinical Transplantation|May 2, 2002
A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysisRobert J Stratta, Rita R Alloway, Ernest Hodge, et al.
Transplantation Proceedings|November 22, 2005
Impact of the metabolic syndrome on long-term outcomes in simultaneous kidney-pancreas transplantationJ Rogers, R J Stratta, A Lo, et al.
Transplantation Proceedings|November 22, 2005
Inferior late functional and metabolic outcomes in African American simultaneous kidney-pancreas recipientsJ Rogers, R J Stratta, A Lo, et al.
Transplantation|April 30, 2003
Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized studyRobert J Stratta, Rita R Alloway, Agnes Lo, et al.
Journal of the Royal Society of Health|August 1, 1997
Lessons to be learned: a case study approach. Hyperactivity and confusion in the presentation of hyoscine overdoseN Ayub, D Donaldson, D Bedford, et al.
Transplantation Proceedings|November 22, 2005
Risk factors and outcomes analyses at 36 months of a prospective, randomized, multicenter, trial of daclizumab induction in simultaneous kidney-pancreas transplant recipientsR J Stratta, R R Alloway, A Lo, et al.
Pageof 17